2004D-0283 - Draft Guidance for Industry:  Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles; Availability

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC1
  



  

  

  



  

  
Submitter : 
  

  
Ms. Linda Duple
  

  
Date & Time: 
  

  
10/12/2004 02:10:35
  



  

  
Organization : 
  

  
Bimeda, Inc.
  



  

  
Drug Industry
  


  

  
Category : 
  


  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
The interpretation would be clearer if distinction/separation could be made between soluble powders and Type A Medicated Articles.